Trana Discovery is an anti-infective drug discovery technology company that helps its partners find new classes of drugs for the treatment of bacterial, viral, and fungal infectious diseases. Our proprietary assays identify compounds that work through a unique mechanism of action: inhibition of the target pathogen’s ability to use transfer RNA (tRNA) essential for propagation.

The use of high-throughput screening assays developed by Trana Discovery provides a low risk, low cost means to deliver drug candidates with a high certainty of effectiveness. Our company provides licensing opportunities for exclusive rights to new drug classes.
Learn how HIV uses tRNA during replication
Learn how our technology can add value to your company
View company information & technology information




  • New Trana HIV 201 HTS Assay screens 50,000 compounds per day more >>

  • Proprietary and patented technology

  • Actively seeking licensing partners for HIV assay

  • Contact us at: info@tranadiscovery.com
    1-866-390-3452 (toll free)
    1-919-342-6192 (int'l)



Dec 2009:Trana Discovery Completes $720,000 Series A Investment Round

Oct 2009: Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds; NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition
More news>

 

• HIV (cause of AIDS)
Staphylococcus aureus including MRSA
• Multi-drug resistant tuberculosis
• Malaria and other diseases of the developing world
• Biodefense-related infectious diseases


Copyright © 2009 Trana Discovery, Inc. All rights reserved
Home | About Us | Technology | Assays | News | Contact | Privacy Policy